Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1943)	5/16/2016 12:33:04 PM
From: Strong Long	Read Replies (1) \| Respond to of 2026

Thanks James, I hope you're right about the efficacy. I do believe that management was trying to get that point across at the KOL event, but the point was lost a bit by the technical nature of the presentation. It's possible that management took they're eye off the ball in Europe and V has suffered because they were so focused on Fis, but it drives me nuts, especially now that we're post Fis, when they miss things as simple as communicating the timing for the NDA resubmission...something you had to bring to their attention. How do they miss something like that? Management needs to step up there game and quite making mistakes...or at least make fewer of them.